MX2016012372A - Composiciones inmunologicas que contienen histophilus somni atenuado. - Google Patents
Composiciones inmunologicas que contienen histophilus somni atenuado.Info
- Publication number
- MX2016012372A MX2016012372A MX2016012372A MX2016012372A MX2016012372A MX 2016012372 A MX2016012372 A MX 2016012372A MX 2016012372 A MX2016012372 A MX 2016012372A MX 2016012372 A MX2016012372 A MX 2016012372A MX 2016012372 A MX2016012372 A MX 2016012372A
- Authority
- MX
- Mexico
- Prior art keywords
- histophilus somni
- compositions containing
- immunological compositions
- strains
- attenuated histophilus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Esta descripción proporciona cepas de Histophilus somni atenuadas, composiciones que las comprenden, y métodos de producción y uso de las mismas. Las cepas atenuadas pueden expresar niveles menores o ninguno de varios genes asociados con virulencia, con relación a las bacterias patogénicas correspondientes. Ventajosamente, las cepas de Histophilus somni atenuadas se pueden administrar oralmente, intranasalmente, intra-traquealmente o subcutáneamente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461970195P | 2014-03-25 | 2014-03-25 | |
PCT/US2015/022519 WO2015148687A2 (en) | 2014-03-25 | 2015-03-25 | Immunological compositions containing attenuated histophilus somni |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016012372A true MX2016012372A (es) | 2017-05-30 |
Family
ID=52829377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016012372A MX2016012372A (es) | 2014-03-25 | 2015-03-25 | Composiciones inmunologicas que contienen histophilus somni atenuado. |
Country Status (19)
Country | Link |
---|---|
US (2) | US9592283B2 (es) |
EP (2) | EP3488862B1 (es) |
JP (1) | JP6405390B2 (es) |
KR (1) | KR101924271B1 (es) |
CN (1) | CN107197626B (es) |
AU (1) | AU2015236052B2 (es) |
BR (1) | BR112016021918A2 (es) |
CA (1) | CA2943786C (es) |
CL (1) | CL2016002402A1 (es) |
DK (1) | DK3488862T3 (es) |
EA (1) | EA038530B1 (es) |
ES (1) | ES2927971T3 (es) |
HU (1) | HUE059284T2 (es) |
MX (1) | MX2016012372A (es) |
NZ (1) | NZ724908A (es) |
PH (1) | PH12016501879A1 (es) |
PL (1) | PL3488862T3 (es) |
TR (1) | TR201907352T4 (es) |
WO (1) | WO2015148687A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107197626B (zh) * | 2014-03-25 | 2021-03-02 | 勃林格殷格翰动物保健美国公司 | 含有减毒睡眠嗜组织菌的免疫组合物 |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
CR20200014A (es) | 2017-07-14 | 2020-06-11 | Immatics Biotechnologies Gmbh | Molécula de polipéptido con especificidad dual mejorada |
US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
RU2754005C1 (ru) * | 2020-10-29 | 2021-08-25 | Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук" (ФГБНУ ФНЦ ВИЭВ РАН) | Штамм бактерий histophilus somni, предназначенный для получения моно- и поливалентных иммуногенных композиций, направленных на специфическую профилактику гистофилеза (стадного бесплодия) рогатого скота |
US20220372165A1 (en) | 2021-05-05 | 2022-11-24 | Immatics Biotechnologies Gmbh | Antigen binding proteins specifically binding prame |
CN113174374B (zh) * | 2021-05-19 | 2022-07-22 | 西南民族大学 | 一种牛病毒性腹泻病毒弱毒株及其用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0138854B1 (en) | 1983-03-08 | 1992-11-04 | Chiron Mimotopes Pty. Ltd. | Antigenically active amino acid sequences |
EP0930893B1 (en) | 1996-10-11 | 2005-04-13 | The Regents of The University of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
US5980912A (en) | 1997-03-25 | 1999-11-09 | Zonagen, Inc. | Chitosan induced immunopotentiation |
WO2000018429A2 (en) * | 1998-09-25 | 2000-04-06 | The Regents Of The University Of California | Vaccine based on attenuated $i(haemophilus somnus) |
US6770273B1 (en) * | 1998-09-25 | 2004-08-03 | Regents Of The University Of California | Vaccine based on attenuated Haemophilus somnus |
US20090068223A1 (en) * | 2005-11-15 | 2009-03-12 | Boehringer Ingelheim Vetmedica, Inc. | Combination vaccine comprising an attenuated bovine viral diarrhea virus |
US8586059B2 (en) * | 2008-07-03 | 2013-11-19 | Iowa State University Research Foundation, Inc. | Cattle vaccines |
US9597386B2 (en) * | 2012-04-05 | 2017-03-21 | Boehringer Ingelheim Vetmedica, Inc. | Outer membrane proteins of Histophilus somni and methods thereof |
ES2824402T3 (es) * | 2013-11-01 | 2021-05-12 | Boehringer Ingelheim Animal Health Usa Inc | Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas |
CN107197626B (zh) * | 2014-03-25 | 2021-03-02 | 勃林格殷格翰动物保健美国公司 | 含有减毒睡眠嗜组织菌的免疫组合物 |
-
2015
- 2015-03-25 CN CN201580020906.2A patent/CN107197626B/zh active Active
- 2015-03-25 CA CA2943786A patent/CA2943786C/en active Active
- 2015-03-25 DK DK18210524.7T patent/DK3488862T3/da active
- 2015-03-25 PL PL18210524.7T patent/PL3488862T3/pl unknown
- 2015-03-25 KR KR1020167029686A patent/KR101924271B1/ko active IP Right Grant
- 2015-03-25 NZ NZ724908A patent/NZ724908A/en not_active IP Right Cessation
- 2015-03-25 EA EA201691915A patent/EA038530B1/ru unknown
- 2015-03-25 EP EP18210524.7A patent/EP3488862B1/en active Active
- 2015-03-25 BR BR112016021918A patent/BR112016021918A2/pt not_active Application Discontinuation
- 2015-03-25 HU HUE18210524A patent/HUE059284T2/hu unknown
- 2015-03-25 WO PCT/US2015/022519 patent/WO2015148687A2/en active Application Filing
- 2015-03-25 AU AU2015236052A patent/AU2015236052B2/en active Active
- 2015-03-25 JP JP2016559361A patent/JP6405390B2/ja active Active
- 2015-03-25 ES ES18210524T patent/ES2927971T3/es active Active
- 2015-03-25 US US14/668,656 patent/US9592283B2/en active Active
- 2015-03-25 TR TR2019/07352T patent/TR201907352T4/tr unknown
- 2015-03-25 MX MX2016012372A patent/MX2016012372A/es active IP Right Grant
- 2015-03-25 EP EP15716266.0A patent/EP3122374B1/en active Active
-
2016
- 2016-09-23 PH PH12016501879A patent/PH12016501879A1/en unknown
- 2016-09-23 CL CL2016002402A patent/CL2016002402A1/es unknown
-
2017
- 2017-01-30 US US15/419,568 patent/US10098941B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20170157232A1 (en) | 2017-06-08 |
JP6405390B2 (ja) | 2018-10-17 |
TR201907352T4 (tr) | 2019-06-21 |
US20150273045A1 (en) | 2015-10-01 |
EP3488862B1 (en) | 2022-05-04 |
AU2015236052A1 (en) | 2016-11-10 |
EP3122374A2 (en) | 2017-02-01 |
ES2927971T3 (es) | 2022-11-14 |
EP3122374B1 (en) | 2019-02-20 |
KR20160128427A (ko) | 2016-11-07 |
EA201691915A1 (ru) | 2017-04-28 |
JP2017517245A (ja) | 2017-06-29 |
US10098941B2 (en) | 2018-10-16 |
CA2943786C (en) | 2023-12-12 |
BR112016021918A2 (pt) | 2017-10-24 |
WO2015148687A3 (en) | 2015-12-23 |
HUE059284T2 (hu) | 2022-11-28 |
WO2015148687A2 (en) | 2015-10-01 |
PH12016501879B1 (en) | 2017-01-09 |
EP3488862A1 (en) | 2019-05-29 |
CN107197626A (zh) | 2017-09-22 |
PL3488862T3 (pl) | 2022-08-29 |
KR101924271B1 (ko) | 2019-02-22 |
AU2015236052B2 (en) | 2018-05-10 |
CA2943786A1 (en) | 2015-10-01 |
US9592283B2 (en) | 2017-03-14 |
DK3488862T3 (da) | 2022-08-01 |
PH12016501879A1 (en) | 2017-01-09 |
EA038530B1 (ru) | 2021-09-10 |
CL2016002402A1 (es) | 2017-05-26 |
CN107197626B (zh) | 2021-03-02 |
NZ724908A (en) | 2017-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501879A1 (en) | Immunological composition containing attenuated histophilus somni | |
WO2016033439A3 (en) | Compositions and methods for the treating an inflammatory disease or disorder | |
PH12018500950A1 (en) | Subcutaneous formulations of anti-cd38 antibodies and their uses | |
PH12016501763A1 (en) | Multispecific antibodies | |
MX2016014807A (es) | Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados. | |
PH12016502586A1 (en) | Lipid comprising docosapentaenoic acid | |
MD4733B1 (ro) | Anticorpi anti-TIGIT | |
AU2015296298A8 (en) | Flagellin-based agents and uses including effective vaccination | |
PH12016502555A1 (en) | Methods of preparing substituted nucleotide analogs | |
PH12014502855A1 (en) | Attenuated streptococcus suis vaccines and methods of making and use thereof | |
MX2017006701A (es) | Fórmula infantil con rrr-alfa-tocoferol,2'-fucosilactosa y un probiótico. | |
EP3620178A3 (en) | Antisense antibacterial compounds and methods | |
SG10201900041VA (en) | Meningococcus vaccines | |
IN2014MU00455A (es) | ||
MX2018005785A (es) | Conjugados de anticuerpo anti-cd22-maytansina y metodos de uso de los mismos. | |
MX2021006458A (es) | Pared celular de levadura enriquecida en proteina de manano-oligosacarido. | |
MX2017016401A (es) | Composiciones inmunogenas. | |
MX2019000677A (es) | Células miméticas de células b. | |
MX2019005535A (es) | Streptococcus thermophilus para uso en la preparación de productos fermentados. | |
PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
PH12016501326A1 (en) | (s)-3'-methyl-abscisic acid and esters thereof | |
NZ732618A (en) | Multivalent ligand-lipid constructs | |
WO2015159155A3 (en) | Novel ademetionine formulations | |
WO2015169773A3 (en) | Mutants of spy0269 | |
MA39900A (fr) | Vaccins à base d'acide nucléique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. |
|
FG | Grant or registration |